4DMedical's Imaging Technology: Advancing Cardio-Pulmonary Diagnostics

Andreas Fouras Founder, MD, CEO & Director Hey, everybody. It's really great to have such a big crowd on here today. Such strong interest in continuing to stay in touch with the 4DX story. So thank you, thank you very much. We have the usual legals. I'm going to spend a little time taking everyone back to the core of where we are. And we are a Melbourne-based company that is here to bring imaging software to the world. And we have a portfolio of structural and functional imaging technologies protected by 100 patents and represented by 9 FDA-cleared devices. We are a small but mighty team of 130 people where our U.S. folks are concentrated on our customer-facing efforts, and Australia covers the engineering, R&D and support capabilities with overwhelming majority of folks being based out of Australia. We have incredible technical and clinical expertise, and we have great brands supporting our distribution. Here is the portfolio of products. And we spread now across the heart and the lungs. And we have a combination of products that cover the entire portfolio. And one of the lessons we've learned over the last -- over our years of being in the market, and I'm sure that most of you recognize and acknowledge that it's really been since our generation 3 product CT:VQ has been to market that we've really had our breakout moment. But we've been working hard in the years before that. And one of the key lessons that we've learned is by having a full service offering, by having the full coverage of everything that a hospital needs to cover lungs or as much as possible heart and